is a method for the diagnosis and treatment of a disease state or condition mediated by a FGFR kinase, which method comprises (i) screening a patient to determine whether a disease or condition from which the patient is or may be suffering is one which would be susceptible to treatment with a compound having activity against FGFR; and (ii) where it is indicated that the disease or condition from w